{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 1075, "items": [{"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T13:03:12Z", "timestamp": 1576846992245}, "reference-count": 0, "publisher": "The Endocrine Society", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Clinical Endocrinology & Metabolism"], "published-print": {"date-parts": [[1999, 1, 1]]}, "DOI": "10.1210/jc.84.1.165", "type": "journal-article", "created": {"date-parts": [[2004, 2, 25]], "date-time": "2004-02-25T21:56:42Z", "timestamp": 1077746202000}, "page": "165-169", "source": "Crossref", "is-referenced-by-count": 445, "title": ["Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women"], "prefix": "10.1210", "volume": "84", "author": [{"given": "R. S.", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "80", "container-title": ["Journal of Clinical Endocrinology & Metabolism"], "language": "en", "link": [{"URL": "http://press.endocrine.org/doi/full/10.1210/jcem.84.1.5393", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 2]], "date-time": "2016-12-02T22:19:12Z", "timestamp": 1480717152000}, "score": 95.41771, "issued": {"date-parts": [[1999, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1210/jc.84.1.165", "ISSN": ["0021-972X"], "issn-type": [{"value": "0021-972X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:25:47Z", "timestamp": 1574123147023}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Obstetrical & Gynecological Survey"], "published-print": {"date-parts": [[1999, 6]]}, "DOI": "10.1097/00006254-199906000-00019", "type": "journal-article", "created": {"date-parts": [[2003, 4, 24]], "date-time": "2003-04-24T14:46:36Z", "timestamp": 1051195596000}, "page": "385-386", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome"], "prefix": "10.1097", "volume": "54", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}, {"given": "Allen R.", "family": "Kunselman", "sequence": "additional", "affiliation": []}, {"given": "William C.", "family": "Dodson", "sequence": "additional", "affiliation": []}, {"given": "Andrea", "family": "Dunaif", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Obstetrical & Gynecological Survey"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T01:01:14Z", "timestamp": 1518138074000}, "score": 89.10949, "subtitle": ["A Prospective, Controlled Study in 254 Affected Women"], "issued": {"date-parts": [[1999, 6]]}, "references-count": 0, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.1097/00006254-199906000-00019", "ISSN": ["0029-7828"], "issn-type": [{"value": "0029-7828", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T01:27:50Z", "timestamp": 1575422870017}, "reference-count": 0, "publisher": "The Endocrine Society", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Journal of Clinical Endocrinology & Metabolism"], "published-print": {"date-parts": [[1999, 1]]}, "DOI": "10.1210/jcem.84.1.5393", "type": "journal-article", "created": {"date-parts": [[2014, 1, 8]], "date-time": "2014-01-08T17:03:29Z", "timestamp": 1389200609000}, "page": "165-169", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1"], "prefix": "10.1210", "volume": "84", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}, {"given": "Allen R.", "family": "Kunselman", "sequence": "additional", "affiliation": []}, {"given": "William C.", "family": "Dodson", "sequence": "additional", "affiliation": []}, {"given": "Andrea", "family": "Dunaif", "sequence": "additional", "affiliation": []}], "member": "80", "container-title": ["The Journal of Clinical Endocrinology & Metabolism"], "language": "en", "link": [{"URL": "http://press.endocrine.org/doi/full/10.1210/jcem.84.1.5393", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 25]], "date-time": "2017-05-25T12:24:24Z", "timestamp": 1495715064000}, "score": 85.32032, "issued": {"date-parts": [[1999, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 1]]}, "issue": "1"}, "alternative-id": ["10.1210/jcem.84.1.5393"], "URL": "http://dx.doi.org/10.1210/jcem.84.1.5393", "ISSN": ["0021-972X", "1945-7197"], "issn-type": [{"value": "0021-972X", "type": "print"}, {"value": "1945-7197", "type": "electronic"}], "subject": ["Clinical Biochemistry", "Biochemistry", "Endocrinology, Diabetes and Metabolism", "Endocrinology", "Biochemistry, medical"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T01:26:37Z", "timestamp": 1575422797759}, "reference-count": 0, "publisher": "The Endocrine Society", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Journal of Clinical Endocrinology & Metabolism"], "published-print": {"date-parts": [[1999, 8]]}, "DOI": "10.1210/jcem.84.8.5939-4", "type": "journal-article", "created": {"date-parts": [[2014, 1, 8]], "date-time": "2014-01-08T17:04:31Z", "timestamp": 1389200671000}, "page": "2975-2976", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome\u2014Authors\u2019 Response1"], "prefix": "10.1210", "volume": "84", "author": [{"given": "Andrea", "family": "Dunaif", "sequence": "first", "affiliation": []}, {"given": "Richard S.", "family": "Legro", "sequence": "additional", "affiliation": []}], "member": "80", "container-title": ["The Journal of Clinical Endocrinology & Metabolism"], "language": "en", "link": [{"URL": "http://press.endocrine.org/doi/full/10.1210/jcem.84.8.5939-4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 3, 30]], "date-time": "2017-03-30T22:04:51Z", "timestamp": 1490911491000}, "score": 69.568855, "issued": {"date-parts": [[1999, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 8]]}, "issue": "8"}, "alternative-id": ["10.1210/jcem.84.8.5939-4"], "URL": "http://dx.doi.org/10.1210/jcem.84.8.5939-4", "ISSN": ["0021-972X", "1945-7197"], "issn-type": [{"value": "0021-972X", "type": "print"}, {"value": "1945-7197", "type": "electronic"}], "subject": ["Clinical Biochemistry", "Biochemistry", "Endocrinology, Diabetes and Metabolism", "Endocrinology", "Biochemistry, medical"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T05:56:16Z", "timestamp": 1574142976692}, "reference-count": 54, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Endocrinology & Diabetes"], "published-print": {"date-parts": [[2002, 12]]}, "DOI": "10.1097/00060793-200212000-00003", "type": "journal-article", "created": {"date-parts": [[2003, 4, 21]], "date-time": "2003-04-21T07:41:33Z", "timestamp": 1050910893000}, "page": "451-458", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Diabetes prevalence and risk factors in polycystic ovary syndrome"], "prefix": "10.1097", "volume": "9", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Current Opinion in Endocrinology & Diabetes"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T17:05:29Z", "timestamp": 1518109529000}, "score": 52.73231, "subtitle": [""], "issued": {"date-parts": [[2002, 12]]}, "references-count": 54, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.1097/00060793-200212000-00003", "ISSN": ["1068-3097"], "issn-type": [{"value": "1068-3097", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:18:39Z", "timestamp": 1574216319148}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 7, 1]], "date-time": "2006-07-01T00:00:00Z", "timestamp": 1151712000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Fertility and Sterility"], "published-print": {"date-parts": [[2006, 7]]}, "DOI": "10.1016/j.fertnstert.2006.04.010", "type": "journal-article", "created": {"date-parts": [[2006, 6, 24]], "date-time": "2006-06-24T11:27:02Z", "timestamp": 1151148422000}, "page": "S16-S17", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Type 2 diabetes and polycystic ovary syndrome"], "prefix": "10.1016", "volume": "86", "author": [{"given": "R", "family": "LEGRO", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Fertility and Sterility"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0015028206009113?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0015028206009113?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 15]], "date-time": "2019-01-15T12:54:26Z", "timestamp": 1547556866000}, "score": 50.07378, "issued": {"date-parts": [[2006, 7]]}, "references-count": 0, "alternative-id": ["S0015028206009113"], "URL": "http://dx.doi.org/10.1016/j.fertnstert.2006.04.010", "ISSN": ["0015-0282"], "issn-type": [{"value": "0015-0282", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 16]], "date-time": "2019-12-16T22:17:30Z", "timestamp": 1576534650722}, "reference-count": 0, "publisher": "Oxford University Press", "isbn-type": [{"value": "9780199235292", "type": "print"}, {"value": "9780199608232", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011, 7]]}, "abstract": "<p>Polycystic ovary syndrome (PCOS) is thought to be primarily a disorder that affects women during their reproductive years. The diagnostic criteria reflect ovarian dysfunction, i.e. hyperandrogenism, anovulation, and polycystic ovaries. However, women with PCOS appear to be uniquely insulin resistant, are frequently obese, and may be at risk for a variety of long-term health disorders including diabetes, cardiovascular disease, and cancers. Although the endocrine and reproductive features of the disorder improve with age, the associated metabolic abnormalities, particularly components of the metabolic syndrome, may actually worsen. This chapter will explore the pathophysiology of aberrant insulin action in women with PCOS, recognition of long-term risks, and preventive strategies.</p>", "DOI": "10.1093/med/9780199235292.003.0857", "type": "book-chapter", "created": {"date-parts": [[2011, 7, 15]], "date-time": "2011-07-15T03:30:21Z", "timestamp": 1310700621000}, "page": "1235-1239", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Polycystic ovary syndrome: metabolic aspects"], "prefix": "10.1093", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2011, 7]]}, "container-title": ["Oxford Textbook of Endocrinology and Diabetes"], "original-title": ["Polycystic ovary syndrome: metabolic aspects"], "deposited": {"date-parts": [[2019, 12, 16]], "date-time": "2019-12-16T13:27:44Z", "timestamp": 1576502864000}, "score": 49.752316, "issued": {"date-parts": [[2011, 7]]}, "ISBN": ["9780199235292", "9780199608232"], "references-count": 0, "URL": "http://dx.doi.org/10.1093/med/9780199235292.003.0857"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:51:52Z", "timestamp": 1574416312690}, "reference-count": 0, "publisher": "Informa Healthcare", "isbn-type": [{"value": "9780824707460", "type": "print"}, {"value": "9780203910948", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 4, 3]]}, "DOI": "10.1201/9780203910948.ch20", "type": "book-chapter", "created": {"date-parts": [[2010, 3, 7]], "date-time": "2010-03-07T22:01:49Z", "timestamp": 1267999309000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Dyslipidemia in Polycystic Ovary Syndrome"], "prefix": "10.1201", "author": [{"given": "Richard", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2010, 3, 7]]}, "container-title": ["Polycystic Ovary Syndrome"], "deposited": {"date-parts": [[2010, 3, 7]], "date-time": "2010-03-07T22:02:00Z", "timestamp": 1267999320000}, "score": 49.501724, "subtitle": ["Etiology and Response to Treatment"], "issued": {"date-parts": [[2002, 4, 3]]}, "ISBN": ["9780824707460", "9780203910948"], "references-count": 0, "alternative-id": ["10.1201/9780203910948.ch20", "10.1201/9780203910948"], "URL": "http://dx.doi.org/10.1201/9780203910948.ch20"}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T00:01:02Z", "timestamp": 1575158462786}, "reference-count": 48, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 3, 1]], "date-time": "2001-03-01T00:00:00Z", "timestamp": 983404800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Obstetrics and Gynecology Clinics of North America"], "published-print": {"date-parts": [[2001, 3]]}, "DOI": "10.1016/s0889-8545(05)70188-1", "type": "journal-article", "created": {"date-parts": [[2005, 6, 28]], "date-time": "2005-06-28T16:27:57Z", "timestamp": 1119976077000}, "page": "99-109", "source": "Crossref", "is-referenced-by-count": 32, "title": ["Diabetes Prevalence and Risk Factors in Polycystic Ovary Syndrome"], "prefix": "10.1016", "volume": "28", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Obstetrics and Gynecology Clinics of North America"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0889854505701881?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0889854505701881?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 25]], "date-time": "2019-01-25T00:29:45Z", "timestamp": 1548376185000}, "score": 49.4133, "issued": {"date-parts": [[2001, 3]]}, "references-count": 48, "journal-issue": {"published-print": {"date-parts": [[2001, 3]]}, "issue": "1"}, "alternative-id": ["S0889854505701881"], "URL": "http://dx.doi.org/10.1016/s0889-8545(05)70188-1", "ISSN": ["0889-8545"], "issn-type": [{"value": "0889-8545", "type": "print"}], "subject": ["Obstetrics and Gynaecology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T17:22:28Z", "timestamp": 1576776148571}, "edition-number": "2", "reference-count": 56, "publisher": "Cambridge University Press", "isbn-type": [{"value": "9781107410572", "type": "print"}, {"value": "9780511545191", "type": "electronic"}], "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2009, 9, 29]], "date-time": "2009-09-29T00:00:00Z", "timestamp": 1254182400000}, "delay-in-days": 3193, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2001, 1, 1]]}, "DOI": "10.1017/cbo9780511545191.003", "type": "book-chapter", "created": {"date-parts": [[2009, 12, 22]], "date-time": "2009-12-22T18:40:50Z", "timestamp": 1261507250000}, "page": "25-41", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Phenotype and genotype in polycystic ovary syndrome"], "prefix": "10.1017", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "56", "reference": [{"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib143", "DOI": "10.1210/jcem.84.11.6148", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib189", "DOI": "10.1210/jc.2002-021499", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib141", "DOI": "10.1016/S0002-9378(15)33704-2", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib161", "DOI": "10.1067/mob.2002.126650", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib182", "DOI": "10.1210/jcem.86.1.7274", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib174", "DOI": "10.1016/S0015-0282(16)58687-7", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib162", "DOI": "10.1111/j.1365-2265.2004.01981.x", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib159", "DOI": "10.1080/09513590410001667256", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib167", "DOI": "10.1210/jcem.87.5.8387", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib157", "DOI": "10.1038/sj.ijo.0802911", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib187", "DOI": "10.1046/j.1365-2265.2002.01603.x", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib156", "DOI": "10.1111/j.1365-2265.1988.tb03707.x", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib149", "DOI": "10.1111/j.1365-2265.1979.tb03077.x", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib188", "first-page": "81", "article-title": "Hyperthecosis: an inheritable form of polycystic ovarian disease", "volume": "11", "author": "Wilroy", "year": "1975", "journal-title": "Birth Defects: Orig. Art. Ser"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib153", "DOI": "10.1093/hmg/6.3.397", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib168", "DOI": "10.1136/jmg.37.10.794", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib140", "DOI": "10.1016/0002-9378(92)91779-A", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib165", "DOI": "10.1073/pnas.95.25.14956", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib176", "DOI": "10.1016/S0015-0282(01)01677-6", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib180", "first-page": "1979", "article-title": "Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome", "volume": "81", "author": "Talbot", "year": "1996", "journal-title": "J. Clin. Endocrinol. Metab"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib142", "DOI": "10.1210/jc.2002-021553", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib158", "DOI": "10.1016/S0015-0282(16)57412-3", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib152", "first-page": "4174", "article-title": "Polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries", "volume": "81", "author": "Gharani", "year": "1996", "journal-title": "J. Clin. Endocrinol. Metab"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib169", "DOI": "10.1159/000293493", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib163", "DOI": "10.1126/science.8091226", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib147", "DOI": "10.2337/diabetes.50.9.2164", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib177", "DOI": "10.1007/s00125-002-0836-3", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib138", "DOI": "10.1038/35052543", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib186", "DOI": "10.1016/S0140-6736(96)08368-7", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib185", "first-page": "166", "article-title": "A-type lamin-linked lipodystrophies", "volume": "264", "author": "Vigouroux", "year": "2005", "journal-title": "Novartis Found. Symp"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib151", "DOI": "10.1056/NEJMra025261", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib175", "DOI": "10.1210/jc.2004-2485", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib154", "first-page": "1158", "article-title": "Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries", "volume": "79", "author": "Gilling-Smith", "year": "1994", "journal-title": "J. Clin. Endocrinol. Metab"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib183", "DOI": "10.1073/pnas.96.15.8573", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib150", "DOI": "10.1210/jc.2003-031640", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib173", "DOI": "10.1016/S0015-0282(16)57297-5", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib172", "DOI": "10.1210/mend.13.6.0311", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib166", "DOI": "10.1210/jcem.87.5.8513", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib155", "DOI": "10.1210/jcem.84.1.5382", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib160", "DOI": "10.1016/S0015-0282(00)01662-9", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib179", "first-page": "983", "article-title": "The TDT and other family-based tests for linkage disequilibrium and association", "volume": "59", "author": "Spielman", "year": "1996", "journal-title": "Am. J. Hum. Genet"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib146", "DOI": "10.1210/jcem.87.4.8385", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib145", "DOI": "10.2337/diab.42.10.1462", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib164", "DOI": "10.1016/S0015-0282(02)03275-2", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib178", "DOI": "10.1016/0026-0495(94)90018-3", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib170", "DOI": "10.1016/S0140-6736(05)62990-X", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib139", "DOI": "10.1111/j.1365-2265.1993.tb02150.x", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib144", "DOI": "10.1016/S0015-0282(99)00628-7", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib190", "author": "Dunaif", "year": "1992", "volume-title": "The Polycystic Ovary Syndrome"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib171", "DOI": "10.1067/mob.2000.108020", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib136", "DOI": "10.1210/jc.2003-032046", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib148", "first-page": "4182", "article-title": "High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus", "volume": "85", "author": "Escobar-Morreale", "year": "2000", "journal-title": "J. Clin. Endocrinol. Metab"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib184", "first-page": "4455", "article-title": "Allelic variants of the follistatin gene in polycystic ovary syndrome", "volume": "85", "author": "Urbanek", "year": "2000", "journal-title": "J. Clin. Endocrinol. Metab"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib181", "unstructured": "The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to Polycystic Ovary Syndrome (PCOS). Hum. Reprod. 19:41\u201347.", "DOI": "10.1093/humrep/deh098", "doi-asserted-by": "crossref"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib137", "DOI": "10.1093/humupd/dmg044", "doi-asserted-by": "publisher"}, {"key": "9780511545191.CBO9780511545191A009_CBO9780511545191bib135", "first-page": "810", "article-title": "Clinical review 56: nonclassic adrenal hyperplasia: current concepts", "volume": "78", "author": "Azziz", "year": "1994", "journal-title": "J. Clin. Endocrinol. Metab"}], "container-title": ["Polycystic Ovary Syndrome"], "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/271E60A045A4A1819E3930A76827180D", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T22:46:29Z", "timestamp": 1575326789000}, "score": 48.01579, "issued": {"date-parts": [[2001, 1, 1]]}, "ISBN": ["9780521848497", "9780511545191", "9781107410572"], "references-count": 56, "URL": "http://dx.doi.org/10.1017/cbo9780511545191.003", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T20:09:12Z", "timestamp": 1575058152958}, "reference-count": 34, "publisher": "Elsevier BV", "issue": "8", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 12, 1]], "date-time": "2001-12-01T00:00:00Z", "timestamp": 1007164800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The American Journal of Medicine"], "published-print": {"date-parts": [[2001, 12]]}, "DOI": "10.1016/s0002-9343(01)00948-2", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T10:11:15Z", "timestamp": 1027591875000}, "page": "607-613", "source": "Crossref", "is-referenced-by-count": 284, "title": ["Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome"], "prefix": "10.1016", "volume": "111", "author": [{"given": "Richard S", "family": "Legro", "sequence": "first", "affiliation": []}, {"given": "Allen R", "family": "Kunselman", "sequence": "additional", "affiliation": []}, {"given": "Andrea", "family": "Dunaif", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The American Journal of Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0002934301009482?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0002934301009482?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 3]], "date-time": "2019-05-03T07:20:18Z", "timestamp": 1556868018000}, "score": 47.04885, "issued": {"date-parts": [[2001, 12]]}, "references-count": 34, "journal-issue": {"published-print": {"date-parts": [[2001, 12]]}, "issue": "8"}, "alternative-id": ["S0002934301009482"], "URL": "http://dx.doi.org/10.1016/s0002-9343(01)00948-2", "ISSN": ["0002-9343"], "issn-type": [{"value": "0002-9343", "type": "print"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T22:25:06Z", "timestamp": 1575239106445}, "publisher-location": "Cham", "reference-count": 37, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319455334", "type": "print"}, {"value": "9783319455341", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-3-319-45534-1_9", "type": "book-chapter", "created": {"date-parts": [[2018, 2, 2]], "date-time": "2018-02-02T09:54:35Z", "timestamp": 1517565275000}, "page": "109-117", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Antiestrogens"], "prefix": "10.1007", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 2, 3]]}, "reference": [{"key": "9_CR37", "unstructured": "Palomba S. Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2015;100:1742\u20137.", "DOI": "10.1210/jc.2014-4235", "doi-asserted-by": "crossref"}, {"key": "9_CR1", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1056/NEJMoa1313517", "volume": "371", "author": "RS Legro", "year": "2014", "unstructured": "Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371:119\u201329.", "journal-title": "N Engl J Med"}, {"key": "9_CR2", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/S0015-0282(16)48069-6", "volume": "42", "author": "EY Adashi", "year": "1984", "unstructured": "Adashi EY. Clomiphene citrate: mechanism(s) and site(s) of action\u2013a hypothesis revisited. Fertil Steril. 1984;42:331\u201344.", "journal-title": "Fertil Steril"}, {"key": "9_CR3", "doi-asserted-by": "crossref", "first-page": "551", "DOI": "10.1056/NEJMoa063971", "volume": "356", "author": "RS Legro", "year": "2007", "unstructured": "Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356:551\u201366.", "journal-title": "N Engl J Med"}, {"key": "9_CR4", "first-page": "1617", "volume": "84", "author": "B Imani", "year": "1999", "unstructured": "Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab. 1999;84:1617\u201322.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR5", "doi-asserted-by": "crossref", "first-page": "3458", "DOI": "10.1210/jc.2009-0545", "volume": "94", "author": "ME Rausch", "year": "2009", "unstructured": "Rausch ME, Legro RS, Barnhart HX, et al. Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94:3458\u201366.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR6", "first-page": "676", "volume": "85", "author": "B Imani", "year": "2000", "unstructured": "Imani B, Eijkemans MJ, de Jong FH, et al. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab. 2000;85:676\u201382.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR7", "first-page": "2361", "volume": "83", "author": "B Imani", "year": "1998", "unstructured": "Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab. 1998;83:2361\u20135.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR8", "doi-asserted-by": "crossref", "first-page": "3288", "DOI": "10.1210/jc.2016-1340", "volume": "101", "author": "SL Mumford", "year": "2016", "unstructured": "Mumford SL, Legro RS, Diamond MP, et al. Baseline AMH level associated with ovulation following ovulation induction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2016;101:3288\u201396.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR9", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1016/j.fertnstert.2006.06.050", "volume": "87", "author": "PG McGovern", "year": "2007", "unstructured": "McGovern PG, Legro RS, Myers ER, et al. Utility of screening for other causes of infertility in women with \u201cknown\u201d polycystic ovary syndrome. Fertil Steril. 2007;87:442\u20134.", "journal-title": "Fertil Steril"}, {"key": "9_CR10", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1210/jcem-72-1-83", "volume": "72", "author": "JE Nestler", "year": "1991", "unstructured": "Nestler JE, Powers LP, Matt DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72:83\u20139.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR11", "doi-asserted-by": "crossref", "first-page": "810", "DOI": "10.1210/jc.2009-1908", "volume": "95", "author": "E Stener-Victorin", "year": "2010", "unstructured": "Stener-Victorin E, Holm G, Labrie F, Nilsson L, Janson PO, Ohlsson C. Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome? J Clin Endocrinol Metab. 2010;95:810\u20139.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR12", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1016/S0015-0282(01)02929-6", "volume": "77", "author": "B Imani", "year": "2002", "unstructured": "Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril. 2002;77:91\u20137.", "journal-title": "Fertil Steril"}, {"key": "9_CR13", "doi-asserted-by": "crossref", "first-page": "1230", "DOI": "10.1056/NEJMoa1414827", "volume": "373", "author": "MP Diamond", "year": "2015", "unstructured": "Diamond MP, Legro RS, Coutifaris C, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility. N Engl J Med. 2015;373:1230\u201340.", "journal-title": "N Engl J Med"}, {"key": "9_CR14", "doi-asserted-by": "crossref", "first-page": "1761", "DOI": "10.1016/j.fertnstert.2006.03.014", "volume": "85", "author": "T Tulandi", "year": "2006", "unstructured": "Tulandi T, Martin J, Al-Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006;85:1761\u20135.", "journal-title": "Fertil Steril"}, {"key": "9_CR15", "doi-asserted-by": "crossref", "first-page": "1803", "DOI": "10.1056/NEJMoa1008095", "volume": "366", "author": "MJ Davies", "year": "2012", "unstructured": "Davies MJ, Moore VM, Willson KJ, et al. Reproductive technologies and the risk of birth defects. N Engl J Med. 2012;366:1803\u201313.", "journal-title": "N Engl J Med"}, {"key": "9_CR16", "doi-asserted-by": "crossref", "first-page": "510.e1", "DOI": "10.1016/j.ajog.2008.10.031", "volume": "200", "author": "BS Hurst", "year": "2009", "unstructured": "Hurst BS, Hickman JM, Matthews ML, Usadi RS, Marshburn PB. Novel clomiphene \u201cstair-step\u201d protocol reduces time to ovulation in women with polycystic ovarian syndrome. Am J Obst Gynecol. 2009;200:510.e1\u20134.", "journal-title": "Am J Obst Gynecol"}, {"key": "9_CR17", "unstructured": "Lobo RA, Granger LR, Davajan V, Mishell Jr DR. An extended regimen of clomiphene citrate in women unresponsive to standard therapy. Fertil Steril. 1982;37:762.", "DOI": "10.1016/S0015-0282(16)46335-1", "doi-asserted-by": "crossref"}, {"key": "9_CR18", "doi-asserted-by": "crossref", "first-page": "902", "DOI": "10.1097/AOG.0b013e31824da35c", "volume": "119", "author": "MP Diamond", "year": "2012", "unstructured": "Diamond MP, Kruger M, Santoro N, et al. Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol. 2012;119:902\u20138.", "journal-title": "Obstet Gynecol"}, {"key": "9_CR19", "first-page": "1157", "volume": "6", "author": "X Dong", "year": "2013", "unstructured": "Dong X, Zheng Y, Liao X, Xiong T, Zhang H. Does progesterone-induced endometrial withdrawal bleed before ovulation induction have negative effects on IUI outcomes in patients with polycystic ovary syndrome? Int J Clin Exp Pathol. 2013;6:1157\u201363.", "journal-title": "Int J Clin Exp Pathol"}, {"key": "9_CR20", "unstructured": "Brown J, Farquhar C. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst Rev. 2016;12:CD002249. doi: \n10.1002/14651858.CD002249.pub5\n\n. PMID: 27976369.", "DOI": "10.1002/14651858.CD002249.pub5", "doi-asserted-by": "publisher"}, {"key": "9_CR21", "doi-asserted-by": "crossref", "first-page": "1485", "DOI": "10.1136/bmj.38867.631551.55", "volume": "332", "author": "E Moll", "year": "2006", "unstructured": "Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomiphene citrate plus metformin and clomiphene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ. 2006;332:1485.", "journal-title": "BMJ"}, {"key": "9_CR22", "doi-asserted-by": "crossref", "first-page": "514", "DOI": "10.1016/j.fertnstert.2007.12.002", "volume": "91", "author": "MM Zain", "year": "2009", "unstructured": "Zain MM, Jamaluddin R, Ibrahim A, Norman RJ. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril. 2009;91:514\u201321.", "journal-title": "Fertil Steril"}, {"key": "9_CR23", "doi-asserted-by": "crossref", "first-page": "1492", "DOI": "10.1210/jc.2011-3061", "volume": "97", "author": "L Morin-Papunen", "year": "2012", "unstructured": "Morin-Papunen L, Rantala AS, Unkila-Kallio L, et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab. 2012;97:1492\u2013500.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR24", "doi-asserted-by": "crossref", "first-page": "1477", "DOI": "10.1007/s10815-013-0090-2", "volume": "30", "author": "ME Ghanem", "year": "2013", "unstructured": "Ghanem ME, Elboghdady LA, Hassan M, et al. Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial. J Assist Reprod Genet. 2013;30:1477\u201385.", "journal-title": "J Assist Reprod Genet"}, {"key": "9_CR25", "doi-asserted-by": "crossref", "first-page": "4048", "DOI": "10.1210/jc.2015-2778", "volume": "100", "author": "RS Legro", "year": "2015", "unstructured": "Legro RS, Dodson WC, Kris-Etherton PM, et al. Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100:4048\u201358.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR26", "doi-asserted-by": "crossref", "first-page": "2705", "DOI": "10.1093/oxfordjournals.humrep.a135772", "volume": "10", "author": "AM Clark", "year": "1995", "unstructured": "Clark AM, Ledger W, Galletly C, et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod. 1995;10:2705\u201312.", "journal-title": "Hum Reprod"}, {"key": "9_CR27", "doi-asserted-by": "crossref", "first-page": "1942", "DOI": "10.1056/NEJMoa1505297", "volume": "374", "author": "MA Mutsaerts", "year": "2016", "unstructured": "Mutsaerts MA, van Oers AM, Groen H, et al. Randomized trial of a lifestyle program in obese infertile women. N Engl J Med. 2016;374:1942\u201353.", "journal-title": "N Engl J Med"}, {"key": "9_CR28", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.4103/0974-1208.86085", "volume": "4", "author": "LK Dhaliwal", "year": "2011", "unstructured": "Dhaliwal LK, Suri V, Gupta KR, Sahdev S. Tamoxifen: an alternative to clomiphene in women with polycystic ovary syndrome. J Human Reprod Sci. 2011;4:76\u20139.", "journal-title": "J Human Reprod Sci"}, {"key": "9_CR29", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1080/09513590400015526", "volume": "19", "author": "LG Nardo", "year": "2004", "unstructured": "Nardo LG. Management of anovulatory infertility associated with polycystic ovary syndrome: tamoxifen citrate an effective alternative compound to clomiphene citrate. Gynecol Endocrinol. 2004;19:235\u20138.", "journal-title": "Gynecol Endocrinol"}, {"key": "9_CR30", "doi-asserted-by": "crossref", "first-page": "769", "DOI": "10.1016/j.fertnstert.2011.06.067", "volume": "96", "author": "E Paula Guedes Neto de", "year": "2011", "unstructured": "de Paula Guedes Neto E, Savaris RF, von Eye Corleta H, de Moraes GS, do Amaral Cristovam R, Lessey BA. Prospective, randomized comparison between raloxifene and clomiphene citrate for ovulation induction in polycystic ovary syndrome. Fertil Steril. 2011;96:769\u201373.", "journal-title": "Fertil Steril"}, {"key": "9_CR31", "first-page": "1427", "volume": "7", "author": "M Hajishafiha", "year": "2013", "unstructured": "Hajishafiha M, Dehghan M, Kiarang N, Sadegh-Asadi N, Shayegh SN, Ghasemi-Rad M. Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome. Drug Des Devel Ther. 2013;7:1427\u201331.", "journal-title": "Drug Des Devel Ther"}, {"key": "9_CR32", "doi-asserted-by": "crossref", "first-page": "1001", "DOI": "10.1016/S0015-0282(02)04206-1", "volume": "78", "author": "ME Parsanezhad", "year": "2002", "unstructured": "Parsanezhad ME, Alborzi S, Motazedian S, Omrani G. Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: a prospective, double-blind, placebo-controlled trial. Fertil Steril. 2002;78:1001\u20134.", "journal-title": "Fertil Steril"}, {"key": "9_CR33", "doi-asserted-by": "crossref", "first-page": "1876", "DOI": "10.1056/NEJM199806253382603", "volume": "338", "author": "JE Nestler", "year": "1998", "unstructured": "Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998;338:1876\u201380.", "journal-title": "N Engl J Med"}, {"key": "9_CR34", "doi-asserted-by": "crossref", "first-page": "562", "DOI": "10.1016/S0015-0282(02)04843-4", "volume": "79", "author": "G Ghazeeri", "year": "2003", "unstructured": "Ghazeeri G, Kutteh WH, Bryer-Ash M, Haas D, Ke RW. Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. Fertil Steril. 2003;79:562\u20136.", "journal-title": "Fertil Steril"}, {"key": "9_CR35", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1016/j.ejogrb.2014.06.008", "volume": "180", "author": "AM Ismail", "year": "2014", "unstructured": "Ismail AM, Hamed AH, Saso S, Thabet HH. Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2014;180:148\u201352.", "journal-title": "Eur J Obstet Gynecol Reprod Biol"}, {"key": "9_CR36", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1016/j.fertnstert.2004.07.960", "volume": "83", "author": "AY Rizk", "year": "2005", "unstructured": "Rizk AY, Bedaiwy MA, Al-Inany HG. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril. 2005;83:367\u201370.", "journal-title": "Fertil Steril"}], "container-title": ["Infertility in Women with Polycystic Ovary Syndrome"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-45534-1_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 2, 2]], "date-time": "2018-02-02T09:57:15Z", "timestamp": 1517565435000}, "score": 46.334873, "issued": {"date-parts": [[2018]]}, "ISBN": ["9783319455334", "9783319455341"], "references-count": 37, "URL": "http://dx.doi.org/10.1007/978-3-319-45534-1_9", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T13:48:00Z", "timestamp": 1574344080270}, "publisher-location": "Totowa, NJ", "reference-count": 32, "publisher": "Humana Press", "isbn-type": [{"value": "9781588298317", "type": "print"}, {"value": "9781597451086", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/978-1-59745-108-6_9", "type": "book-chapter", "created": {"date-parts": [[2008, 1, 11]], "date-time": "2008-01-11T09:48:36Z", "timestamp": 1200044916000}, "page": "133-145", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Acquired Polycystic Ovary Syndrome"], "prefix": "10.1007", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}, {"given": "Elizabeth A.", "family": "Winans", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"issue": "8", "key": "9_CR1", "doi-asserted-by": "publisher", "first-page": "365", "DOI": "10.1016/j.tem.2003.08.002", "volume": "14", "author": "S Sam", "year": "2003", "unstructured": "Sam S, Dunaif A. Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 2003;14(8):365\u201370.", "journal-title": "Trends Endocrinol Metab"}, {"key": "9_CR2", "first-page": "217", "volume": "53", "author": "RS Legro", "year": "1998", "unstructured": "Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss JFr, Dunaif A. Phenotype and genotype in polycystic ovary syndrome. Recent Prog in Horm Res 1998; 53:217\u201356.", "journal-title": "Recent Prog in Horm Res"}, {"issue": "1", "key": "9_CR3", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1016/j.fertnstert.2003.10.004", "volume": "81", "author": "Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.", "year": "2004", "unstructured": "Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19\u201325.", "journal-title": "Fertil Steril"}, {"issue": "1", "key": "9_CR4", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1093/humrep/deh098", "volume": "19", "author": "Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.", "year": "2004", "unstructured": "Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19(1):41\u20137.", "journal-title": "Hum Reprod"}, {"issue": "9145", "key": "9_CR5", "doi-asserted-by": "publisher", "first-page": "1970", "DOI": "10.1016/S0140-6736(98)04512-7", "volume": "352", "author": "H Wallace", "year": "1998", "unstructured": "Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998;352(9145):1970\u20133.", "journal-title": "Lancet"}, {"issue": "5", "key": "9_CR6", "doi-asserted-by": "publisher", "first-page": "625", "DOI": "10.1002/ana.10732", "volume": "54", "author": "AG Herzog", "year": "2003", "unstructured": "Herzog AG, Coleman AE, Jacobs AR, et al. Interictal EEG discharges, reproductive hormones, and menstrual disorders in epilepsy. Ann Neurol 2003;54(5):625\u201337.", "journal-title": "Ann Neurol"}, {"issue": "11", "key": "9_CR7", "doi-asserted-by": "crossref", "first-page": "2133", "DOI": "10.1212/WNL.57.11.2133", "volume": "57", "author": "AG Herzog", "year": "2001", "unstructured": "Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology 2001;57(11):2133\u20135.", "journal-title": "Neurology"}, {"issue": "8", "key": "9_CR8", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1016/S1059-1311(03)00195-X", "volume": "12", "author": "S Svalheim", "year": "2003", "unstructured": "Svalheim S, Tauboll E, Bjornenak T, et al. Do women with epilepsy have increased frequency of menstrual disturbances? Seizure 2003;12(8):529\u201333.", "journal-title": "Seizure"}, {"issue": "6", "key": "9_CR9", "doi-asserted-by": "publisher", "first-page": "704", "DOI": "10.1002/ana.10391", "volume": "52", "author": "MJ Morrell", "year": "2002", "unstructured": "Morrell MJ, Giudice L, Flynn KL, et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002;52(6):704\u201311.", "journal-title": "Ann Neurol"}, {"issue": "6 Suppl 3", "key": "9_CR10", "doi-asserted-by": "crossref", "first-page": "S23", "DOI": "10.1212/WNL.66.66_suppl_3.S23", "volume": "66", "author": "AG. Herzog", "year": "2006", "unstructured": "Herzog AG. Menstrual disorders in women with epilepsy. Neurology 2006;66(6 Suppl 3):S23\u20138.", "journal-title": "Neurology"}, {"issue": "4", "key": "9_CR11", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1001/archneur.1986.00520040029014", "volume": "43", "author": "AG Herzog", "year": "1986", "unstructured": "Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 1986;43(4):341\u20136.", "journal-title": "Arch Neurol"}, {"issue": "2", "key": "9_CR12", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1212/WNL.44.2.306", "volume": "44", "author": "FW Drislane", "year": "1994", "unstructured": "Drislane FW, Coleman AE, Schomer DL, et al. Altered pulsatile secretion of luteinizing hormone in women with epilepsy. Neurology 1994;44(2):306\u201310.", "journal-title": "Neurology"}, {"issue": "12", "key": "9_CR13", "doi-asserted-by": "crossref", "first-page": "1607", "DOI": "10.1212/WNL.36.12.1607", "volume": "36", "author": "AG. Herzog", "year": "1986", "unstructured": "Herzog AG. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 1986;36(12):1607\u201310.", "journal-title": "Neurology"}, {"key": "9_CR14", "doi-asserted-by": "publisher", "first-page": "1383", "DOI": "10.1056/NEJM199311043291904", "volume": "329", "author": "JI Isojarvi", "year": "1993", "unstructured": "Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383\u20138.", "journal-title": "N Engl J Med"}, {"issue": "7", "key": "9_CR15", "doi-asserted-by": "publisher", "first-page": "676", "DOI": "10.1111/j.1528-1157.1995.tb01045.x", "volume": "36", "author": "JI Isojarvi", "year": "1995", "unstructured": "Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV. Menstrual disorders in women with epilepsy receiving carbamazepine. Epilepsia 1995;36(7):676\u201381.", "journal-title": "Epilepsia"}, {"key": "9_CR16", "unstructured": "Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: A D, JR G, F H, GR M, eds. Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific; 1992:377\u201384."}, {"key": "9_CR17", "doi-asserted-by": "publisher", "first-page": "446", "DOI": "10.1002/ana.410430406", "volume": "43", "author": "JI Isojarvi", "year": "1998", "unstructured": "Isojarvi JI, Rattya J, Myllyla VV, et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446\u201351.", "journal-title": "Ann Neurol"}, {"issue": "2\u20133", "key": "9_CR18", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1016/S0920-1211(03)00085-8", "volume": "54", "author": "MJ Morrell", "year": "2003", "unstructured": "Morrell MJ, Isojarvi J, Taylor AE, et al. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res 2003;54(2\u20133):189\u201399.", "journal-title": "Epilepsy Res"}, {"issue": "7", "key": "9_CR19", "doi-asserted-by": "publisher", "first-page": "835", "DOI": "10.1007/s00415-002-0731-3", "volume": "249", "author": "G Luef", "year": "2002", "unstructured": "Luef G, Abraham I, Haslinger M, et al. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. J Neurol 2002;249(7):835\u201341.", "journal-title": "J Neurol"}, {"issue": "1\u20132", "key": "9_CR20", "doi-asserted-by": "publisher", "first-page": "91", "DOI": "10.1016/S0920-1211(01)00317-5", "volume": "48", "author": "G Luef", "year": "2002", "unstructured": "Luef G, Abraham I, Trinka E, et al. Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate. Epilepsy Res 2002;48(1\u20132):91\u2013102.", "journal-title": "Epilepsy Res"}, {"key": "9_CR21", "first-page": "825", "volume": "47", "author": "H Matsunaga", "year": "1993", "unstructured": "Matsunaga H, Sarai M. Elevated serum LH and androgens in affective disorder related to the menstrual cycle: with reference to polycystic ovary syndrome. Jpn J Psychiatry Neurol 1993;47: 825\u201342.", "journal-title": "Jpn J Psychiatry Neurol"}, {"issue": "3", "key": "9_CR22", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.4088/JCP.v61n0305", "volume": "61", "author": "NL Rasgon", "year": "2000", "unstructured": "Rasgon NL, Altshuler LL, Gudeman D, et al. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. J Clin Psychiatry 2000;61(3):173\u20138.", "journal-title": "J Clin Psychiatry"}, {"issue": "4", "key": "9_CR23", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.4088/JCP.v63n0409", "volume": "63", "author": "C O\u2019Donovan", "year": "2002", "unstructured": "O\u2019Donovan C, Kusumakar V, Graves GR, Bird DC. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder. J Clin Psychiatry 2002;63(4):322\u201330.", "journal-title": "J Clin Psychiatry"}, {"issue": "1", "key": "9_CR24", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/S0278-5846(02)00341-X", "volume": "27", "author": "F Akdeniz", "year": "2003", "unstructured": "Akdeniz F, Taneli F, Noyan A, Yuncu Z, Vahip S. Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women? Prog Neuropsychopharmacol Biol Psychiatry 2003;27(1):115\u201321.", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"issue": "11", "key": "9_CR25", "doi-asserted-by": "publisher", "first-page": "1078", "DOI": "10.1016/j.biopsych.2005.10.017", "volume": "59", "author": "H Joffe", "year": "2006", "unstructured": "Joffe H, Cohen LS, Suppes T, et al. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry 2006;59(11):1078\u201386.", "journal-title": "Biol Psychiatry"}, {"issue": "6", "key": "9_CR26", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.1016/S1059-1311(03)00065-7", "volume": "12", "author": "T Betts", "year": "2003", "unstructured": "Betts T, Yarrow H, Dutton N, Greenhill L, Rolfe T. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy. Seizure 2003;12(6):323\u20139.", "journal-title": "Seizure"}, {"issue": "1", "key": "9_CR27", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1034/j.1399-5618.2000.020105.x", "volume": "2", "author": "JC. Soares", "year": "2000", "unstructured": "Soares JC. Valproate treatment and the risk of hyperandrogenism and polycystic ovaries. Bipolar Disorders 2000;2(1):37\u201341.", "journal-title": "Bipolar Disorders"}, {"issue": "8", "key": "9_CR28", "doi-asserted-by": "publisher", "first-page": "1014", "DOI": "10.1046/j.1528-1157.2003.60702.x", "volume": "44", "author": "E Tauboll", "year": "2003", "unstructured": "Tauboll E, Gregoraszczuk EL, Kolodziej A, Kajta M, Ropstad E. Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells. Epilepsia 2003;44(8):1014\u201321.", "journal-title": "Epilepsia"}, {"key": "9_CR29", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1007/BF03349709", "volume": "18", "author": "V Popovic", "year": "1995", "unstructured": "Popovic V, Spremovic S. The effect of sodium valproate on luteinizing hormone secretion in women with polycystic ovary disease. J Endocrinol Invest 1995;18:104\u20138.", "journal-title": "J Endocrinol Invest"}, {"issue": "7", "key": "9_CR30", "doi-asserted-by": "publisher", "first-page": "2520", "DOI": "10.1210/jc.81.7.2520", "volume": "81", "author": "V Popovic", "year": "1996", "unstructured": "Popovic V, Spremovic-Radjenovic S, Eric-Marinkovic J, Grossman A. Effect of sodium valproate on luteinizing hormone secretion in pre- and postmenopausal women and its modulation by naloxone infusion. J Clin Endocrinol Metab 1996;81(7):2520\u20134.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "2", "key": "9_CR31", "doi-asserted-by": "publisher", "first-page": "799", "DOI": "10.1210/en.2003-0940", "volume": "145", "author": "VL Nelson-DeGrave", "year": "2004", "unstructured": "Nelson-DeGrave VL, Wickenheisser JK, Cockrell JE, et al. Valproate potentiates androgen biosynthesis in human ovarian theca cells. Endocrinology 2004;145(2):799\u2013808.", "journal-title": "Endocrinology"}, {"issue": "3", "key": "9_CR32", "doi-asserted-by": "publisher", "first-page": "444", "DOI": "10.1111/j.0013-9580.2005.38404.x", "volume": "46", "author": "CE Fluck", "year": "2005", "unstructured": "Fluck CE, Yaworsky DC, Miller WL. Effects of anticonvulsants on human p450c17 (17alpha-hydroxylase/17,20 lyase) and 3beta-hydroxysteroid dehydrogenase type 2. Epilepsia 2005;46(3): 444\u20138.", "journal-title": "Epilepsia"}], "container-title": ["Contemporary Endocrinology", "Polycystic Ovary Syndrome"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-59745-108-6_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 28]], "date-time": "2019-02-28T20:39:33Z", "timestamp": 1551386373000}, "score": 45.59486, "issued": {"date-parts": [[null]]}, "ISBN": ["9781588298317", "9781597451086"], "references-count": 32, "URL": "http://dx.doi.org/10.1007/978-1-59745-108-6_9", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:21:51Z", "timestamp": 1574270511147}, "reference-count": 31, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2008, 12, 24]], "date-time": "2008-12-24T00:00:00Z", "timestamp": 1230076800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Curr Cardio Risk Rep"], "published-print": {"date-parts": [[2009, 1]]}, "DOI": "10.1007/s12170-009-0011-1", "type": "journal-article", "created": {"date-parts": [[2008, 12, 23]], "date-time": "2008-12-23T13:42:59Z", "timestamp": 1230039779000}, "page": "65-70", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Polycystic ovary syndrome and cardiovascular disease risk"], "prefix": "10.1007", "volume": "3", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 12, 24]]}, "reference": [{"key": "11_CR1", "first-page": "19", "volume": "81", "author": "Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group", "year": "2004", "unstructured": "Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19\u201325.", "journal-title": "Fertil Steril"}, {"key": "11_CR2", "doi-asserted-by": "crossref", "first-page": "2745", "DOI": "10.1210/jc.2003-032046", "volume": "89", "author": "R. Azziz", "year": "2004", "unstructured": "Azziz R, Woods KS, Reyna R, et al.: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004, 89:2745\u20132749.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR3", "first-page": "774", "volume": "18", "author": "A. Dunaif", "year": "1997", "unstructured": "Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18:774\u2013800.", "journal-title": "Endocr Rev"}, {"key": "11_CR4", "doi-asserted-by": "crossref", "first-page": "302", "DOI": "10.1210/er.2003-0004", "volume": "24", "author": "R.S. Legro", "year": "2003", "unstructured": "Legro RS: Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 2003, 24:302\u2013312.", "journal-title": "Endocr Rev"}, {"key": "11_CR5", "doi-asserted-by": "crossref", "first-page": "1276", "DOI": "10.1210/jc.2007-0425", "volume": "93", "author": "L.J. Shaw", "year": "2008", "unstructured": "Shaw LJ, Bairey Merz CN, Azziz R, et al.: Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health\u2014National Heart, Lung, and Blood Institute sponsored Women\u2019s Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008, 93:1276\u20131284.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR6", "doi-asserted-by": "crossref", "first-page": "284", "DOI": "10.1097/GME.0b013e31802cc7ab", "volume": "14", "author": "A.J. Krentz", "year": "2007", "unstructured": "Krentz AJ, von Muhlen D, Barrett-Connor E: Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease. Menopause 2007, 14:284\u2013292.", "journal-title": "Menopause"}, {"key": "11_CR7", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.2147/VHRM.S1452", "volume": "4", "author": "E.O. Talbott", "year": "2008", "unstructured": "Talbott EO, Zborowski J, Rager J, Stragand JR: Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women? Vasc Health Risk Manag 2008, 4:453\u2013462.", "journal-title": "Vasc Health Risk Manag"}, {"key": "11_CR8", "first-page": "2691", "volume": "84", "author": "L. Ibanez", "year": "1999", "unstructured": "Ibanez L, de Zegher F, Potau N: Anovulation after precocious pubarche: early markers and time course in adolescence. J Clin Endocrinol Metab 1999, 84:2691\u20132695.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR9", "doi-asserted-by": "crossref", "first-page": "1820", "DOI": "10.1210/jc.2007-2256", "volume": "93", "author": "S.E. Recabarren", "year": "2008", "unstructured": "Recabarren SE, Smith R, Rios R, et al.: Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008, 93:1820\u20131826.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR10", "unstructured": "Battaglia C, Mancini F, Cianciosi A, et al.: Cardiovascular risk in normal weight, eumenorrheic, nonhirsute daughters of patients with polycystic ovary syndrome: a pilot study. Fertil Steril 2008 Aug 8 (Epub ahead of print)."}, {"key": "11_CR11", "doi-asserted-by": "crossref", "first-page": "1662", "DOI": "10.1210/jc.2007-1958", "volume": "93", "author": "S.C. Kent", "year": "2008", "unstructured": "Kent SC, Gnatuk CL, Kunselman AR, et al.: Hyperan-drogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2008, 93:1662\u20131669.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR12", "doi-asserted-by": "crossref", "first-page": "704", "DOI": "10.1080/09513590701705189", "volume": "23", "author": "O. Lunde", "year": "2007", "unstructured": "Lunde O, Tanbo T: Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15\u201325 years after ovarian wedge resection. Gynecol Endocrinol 2007, 23:704\u2013709.", "journal-title": "Gynecol Endocrinol"}, {"key": "11_CR13", "doi-asserted-by": "crossref", "first-page": "2160", "DOI": "10.1210/jc.2003-031096", "volume": "89", "author": "N. Boulman", "year": "2004", "unstructured": "Boulman N, Levy Y, Leiba R, et al.: Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 2004, 89:2160\u20132165.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR14", "doi-asserted-by": "crossref", "first-page": "2141", "DOI": "10.1210/jc.2007-0190", "volume": "92", "author": "M. Luque-Ramirez", "year": "2007", "unstructured": "Luque-Ramirez M, Alvarez-Blasco F, Mendieta-Azcona C, et al.: Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2007, 92:2141\u20132148.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR15", "doi-asserted-by": "crossref", "first-page": "470", "DOI": "10.1210/jc.2007-1756", "volume": "93", "author": "O. Valkenburg", "year": "2008", "unstructured": "Valkenburg O, Steegers-Theunissen RP, Smedts HP, et al.: A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab 2008, 93:470\u2013476.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR16", "doi-asserted-by": "crossref", "first-page": "1308", "DOI": "10.1111/j.1471-0528.2006.01090.x", "volume": "113", "author": "G.D. Brinkworth", "year": "2006", "unstructured": "Brinkworth GD, Noakes M, Moran LJ, et al.: Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome. BJOG 2006, 113:1308\u20131314.", "journal-title": "BJOG"}, {"key": "11_CR17", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1111/j.1365-2265.2006.02645.x", "volume": "65", "author": "M.B. Sorensen", "year": "2006", "unstructured": "Sorensen MB, Franks S, Robertson C, et al.: Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors. Clin Endocrinol (Oxf) 2006, 65:655\u2013659.", "journal-title": "Clin Endocrinol (Oxf)"}, {"key": "11_CR18", "first-page": "e351", "volume": "119356", "author": "E. Carmina", "year": "2006", "unstructured": "Carmina E, Orio F, Palomba S, et al.: Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 2006, 119:356:e351\u2013e356.", "journal-title": "Am J Med"}, {"key": "11_CR19", "doi-asserted-by": "crossref", "first-page": "4609", "DOI": "10.1210/jc.2007-1343", "volume": "92", "author": "R. Shroff", "year": "2007", "unstructured": "Shroff R, Kerchner A, Maifeld M, et al.: Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab 2007, 92:4609\u20134614.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR20", "doi-asserted-by": "crossref", "first-page": "914", "DOI": "10.1016/j.fertnstert.2006.03.037", "volume": "86", "author": "R.S. Legro", "year": "2006", "unstructured": "Legro RS, Myers ER, Barnhart HX, et al.: The pregnancy in polycystic ovary syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 2006, 86:914\u2013933.", "journal-title": "Fertil Steril"}, {"key": "11_CR21", "doi-asserted-by": "crossref", "first-page": "393", "DOI": "10.1056/NEJMoa012512", "volume": "346", "author": "W.C. Knowler", "year": "2002", "unstructured": "Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393\u2013403.", "journal-title": "N Engl J Med"}, {"key": "11_CR22", "doi-asserted-by": "crossref", "first-page": "3373", "DOI": "10.1210/jc.2008-0751", "volume": "93", "author": "R.L. Thomson", "year": "2008", "unstructured": "Thomson RL, Buckley JD, Noakes M, et al.: The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008, 93:3373\u20133380.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR23", "doi-asserted-by": "crossref", "first-page": "1379", "DOI": "10.1210/jc.2006-2794", "volume": "92", "author": "C. Vigorito", "year": "2007", "unstructured": "Vigorito C, Giallauria F, Palomba S, et al.: Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007, 92:1379\u20131384.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR24", "doi-asserted-by": "crossref", "first-page": "1221", "DOI": "10.1016/j.fertnstert.2007.05.002", "volume": "89", "author": "A. Lindholm", "year": "2008", "unstructured": "Lindholm A, Bixo M, Bjorn I, et al.: Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Fertil Steril 2008, 89:1221\u20131228.", "journal-title": "Fertil Steril"}, {"key": "11_CR25", "doi-asserted-by": "crossref", "first-page": "6364", "DOI": "10.1210/jc.2005-1490", "volume": "90", "author": "H.F. Escobar-Morreale", "year": "2005", "unstructured": "Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, et al.: The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005, 90:6364\u20136369.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR26", "doi-asserted-by": "crossref", "first-page": "741", "DOI": "10.1056/NEJMoa066254", "volume": "357", "author": "L. Sjostrom", "year": "2007", "unstructured": "Sjostrom L, Narbro K, Sjostrom CD, et al.: Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357:741\u2013752.", "journal-title": "N Engl J Med"}, {"key": "11_CR27", "doi-asserted-by": "crossref", "first-page": "551", "DOI": "10.1056/NEJMoa063971", "volume": "356", "author": "R.S. Legro", "year": "2007", "unstructured": "Legro RS, Barnhart HX, Schlaff WD, et al.: Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007, 356:551\u2013566.", "journal-title": "N Engl J Med"}, {"key": "11_CR28", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.2337/dc06-0618", "volume": "30", "author": "C. Meyer", "year": "2007", "unstructured": "Meyer C, McGrath BP, Teede HJ: Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007, 30:471\u2013478.", "journal-title": "Diabetes Care"}, {"key": "11_CR29", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.2337/dc07-1424", "volume": "31", "author": "D. Glintborg", "year": "2008", "unstructured": "Glintborg D, Hojlund K, Andersen M, et al.: Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment. Diabetes Care 2008, 31:328\u2013334.", "journal-title": "Diabetes Care"}, {"key": "11_CR30", "doi-asserted-by": "crossref", "first-page": "2670", "DOI": "10.1210/jc.2008-0115", "volume": "93", "author": "K. Elkind-Hirsch", "year": "2008", "unstructured": "Elkind-Hirsch K, Marrioneaux O, Bhushan M, et al.: Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008, 93:2670\u20132678.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "11_CR31", "doi-asserted-by": "crossref", "first-page": "456", "DOI": "10.1210/jc.2006-1988", "volume": "92", "author": "B. Banaszewska", "year": "2007", "unstructured": "Banaszewska B, Pawelczyk L, Spaczynski RZ, et al.: Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial. J Clin Endocrinol Metab 2007, 92:456\u2013461.", "journal-title": "J Clin Endocrinol Metab"}], "container-title": ["Current Cardiovascular Risk Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s12170-009-0011-1.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s12170-009-0011-1/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s12170-009-0011-1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 2]], "date-time": "2019-06-02T04:55:24Z", "timestamp": 1559451324000}, "score": 45.30433, "issued": {"date-parts": [[2008, 12, 24]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[2009, 1]]}, "issue": "1"}, "alternative-id": ["11"], "URL": "http://dx.doi.org/10.1007/s12170-009-0011-1", "relation": {"cites": []}, "ISSN": ["1932-9520", "1932-9563"], "issn-type": [{"value": "1932-9520", "type": "print"}, {"value": "1932-9563", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:45:59Z", "timestamp": 1574113559470}, "reference-count": 0, "publisher": "The Endocrine Society", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Clinical Endocrinology & Metabolism"], "published-print": {"date-parts": [[1998, 8, 1]]}, "DOI": "10.1210/jc.83.8.2694", "type": "journal-article", "created": {"date-parts": [[2004, 2, 25]], "date-time": "2004-02-25T21:56:42Z", "timestamp": 1077746202000}, "page": "2694-2698", "source": "Crossref", "is-referenced-by-count": 232, "title": ["A Fasting Glucose to Insulin Ratio Is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome"], "prefix": "10.1210", "volume": "83", "author": [{"given": "R. S.", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "80", "container-title": ["Journal of Clinical Endocrinology & Metabolism"], "language": "en", "link": [{"URL": "http://press.endocrine.org/doi/full/10.1210/jcem.83.8.5054", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 2]], "date-time": "2016-12-02T22:18:22Z", "timestamp": 1480717102000}, "score": 44.893753, "issued": {"date-parts": [[1998, 8, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 8, 1]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1210/jc.83.8.2694", "ISSN": ["0021-972X"], "issn-type": [{"value": "0021-972X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T06:21:09Z", "timestamp": 1575267669964}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 9, 1]], "date-time": "2013-09-01T00:00:00Z", "timestamp": 1377993600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Fertility and Sterility"], "published-print": {"date-parts": [[2013, 9]]}, "DOI": "10.1016/j.fertnstert.2013.07.853", "type": "journal-article", "created": {"date-parts": [[2013, 8, 27]], "date-time": "2013-08-27T22:39:32Z", "timestamp": 1377643172000}, "page": "S361", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Fasting glucose levels do not predict impaired glucose tolerance (IGT) in polycystic ovary synrome (PCOS)"], "prefix": "10.1016", "volume": "100", "author": [{"given": "H.", "family": "Kuang", "sequence": "first", "affiliation": []}, {"given": "P.", "family": "Vellanki", "sequence": "additional", "affiliation": []}, {"given": "W.C.", "family": "Dodson", "sequence": "additional", "affiliation": []}, {"given": "A.R.", "family": "Kunselman", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Dunaif", "sequence": "additional", "affiliation": []}, {"given": "R.S.", "family": "Legro", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Fertility and Sterility"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0015028213016324?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0015028213016324?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 3]], "date-time": "2018-11-03T05:33:04Z", "timestamp": 1541223184000}, "score": 44.46741, "issued": {"date-parts": [[2013, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 9]]}, "issue": "3"}, "alternative-id": ["S0015028213016324"], "URL": "http://dx.doi.org/10.1016/j.fertnstert.2013.07.853", "ISSN": ["0015-0282"], "issn-type": [{"value": "0015-0282", "type": "print"}], "subject": ["Obstetrics and Gynaecology", "Reproductive Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T22:04:27Z", "timestamp": 1575151467471}, "reference-count": 0, "publisher": "The Endocrine Society", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Journal of Clinical Endocrinology & Metabolism"], "published-print": {"date-parts": [[2005, 6]]}, "DOI": "10.1210/jc.2004-1843", "type": "journal-article", "created": {"date-parts": [[2005, 5, 25]], "date-time": "2005-05-25T21:44:09Z", "timestamp": 1117057449000}, "page": "3236-3242", "source": "Crossref", "is-referenced-by-count": 176, "title": ["Changes in Glucose Tolerance over Time in Women with Polycystic Ovary Syndrome: A Controlled Study"], "prefix": "10.1210", "volume": "90", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}, {"given": "Carol L.", "family": "Gnatuk", "sequence": "additional", "affiliation": []}, {"given": "Allen R.", "family": "Kunselman", "sequence": "additional", "affiliation": []}, {"given": "Andrea", "family": "Dunaif", "sequence": "additional", "affiliation": []}], "member": "80", "container-title": ["The Journal of Clinical Endocrinology & Metabolism"], "language": "en", "link": [{"URL": "http://press.endocrine.org/doi/full/10.1210/jc.2004-1843", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 3, 30]], "date-time": "2017-03-30T22:23:16Z", "timestamp": 1490912596000}, "score": 43.63967, "issued": {"date-parts": [[2005, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 6]]}, "issue": "6"}, "alternative-id": ["10.1210/jc.2004-1843"], "URL": "http://dx.doi.org/10.1210/jc.2004-1843", "ISSN": ["0021-972X", "1945-7197"], "issn-type": [{"value": "0021-972X", "type": "print"}, {"value": "1945-7197", "type": "electronic"}], "subject": ["Clinical Biochemistry", "Biochemistry", "Endocrinology, Diabetes and Metabolism", "Endocrinology", "Biochemistry, medical"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T18:08:42Z", "timestamp": 1574273322000}, "reference-count": 23, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Obstetrics and Gynecology"], "published-print": {"date-parts": [[2007, 3]]}, "DOI": "10.1097/grf.0b013e31803057ed", "type": "journal-article", "created": {"date-parts": [[2007, 2, 15]], "date-time": "2007-02-15T09:04:36Z", "timestamp": 1171530276000}, "page": "295-304", "source": "Crossref", "is-referenced-by-count": 22, "title": ["Pregnancy Considerations in Women With Polycystic Ovary Syndrome"], "prefix": "10.1097", "volume": "50", "author": [{"given": "RICHARD S.", "family": "LEGRO", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Clinical Obstetrics and Gynecology"], "language": "en", "deposited": {"date-parts": [[2019, 1, 17]], "date-time": "2019-01-17T15:12:15Z", "timestamp": 1547737935000}, "score": 43.108177, "subtitle": [""], "issued": {"date-parts": [[2007, 3]]}, "references-count": 23, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1097/grf.0b013e31803057ed", "ISSN": ["0009-9201"], "issn-type": [{"value": "0009-9201", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:22:58Z", "timestamp": 1574400178739}, "publisher-location": "Totowa, NJ", "reference-count": 52, "publisher": "Humana Press", "isbn-type": [{"value": "9781588297631", "type": "print"}, {"value": "9781597453103", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2007]]}, "DOI": "10.1007/978-1-59745-310-3_25", "type": "book-chapter", "created": {"date-parts": [[2009, 12, 21]], "date-time": "2009-12-21T13:18:12Z", "timestamp": 1261401492000}, "page": "335-348", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Long-Term Sequelae of Polycystic Ovary Syndrome"], "prefix": "10.1007", "author": [{"given": "Richard S.", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "25_CR1", "doi-asserted-by": "publisher", "first-page": "599", "DOI": "10.3109/00016349209006227", "volume": "71", "author": "E. Dahlgren", "year": "1992", "unstructured": "Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstetricia et Gynecologica Scandinavica 1992;71:599\u2013604.", "journal-title": "Acta Obstetricia et Gynecologica Scandinavica"}, {"key": "25_CR2", "doi-asserted-by": "publisher", "first-page": "356", "DOI": "10.1001/jama.287.3.356", "volume": "287", "author": "E.S. Ford", "year": "2002", "unstructured": "Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356\u2013359.", "journal-title": "JAMA"}, {"key": "25_CR3", "doi-asserted-by": "publisher", "first-page": "2289", "DOI": "10.2337/diacare.28.9.2289", "volume": "28", "author": "R. Kahn", "year": "2005", "unstructured": "Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289\u20132304.", "journal-title": "Diabetes Care"}, {"key": "25_CR4", "doi-asserted-by": "publisher", "first-page": "4006", "DOI": "10.1210/jc.84.11.4006", "volume": "84", "author": "E. Diamanti-Kandarakis", "year": "1999", "unstructured": "Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006\u20134011.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR5", "doi-asserted-by": "publisher", "first-page": "1929", "DOI": "10.1210/jc.2004-1045", "volume": "90", "author": "T. Apridonidze", "year": "2005", "unstructured": "Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929\u20131935.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR6", "doi-asserted-by": "publisher", "first-page": "48", "DOI": "10.1210/jc.2005-1329", "volume": "91", "author": "D.A. Ehrmann", "year": "2006", "unstructured": "Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 2006;91:48\u201353.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR7", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1067/mob.2001.109596", "volume": "184", "author": "S. Korhonen", "year": "2001", "unstructured": "Korhonen S, Hippelainen M, Niskanen L, Vanhala M, Saarikoski S. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am J Obstet Gynecol 2001;184:289\u2013296.", "journal-title": "Am J Obstet Gynecol"}, {"key": "25_CR8", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.2337/diacare.22.1.141", "volume": "22", "author": "D.A. Ehrmann", "year": "1999", "unstructured": "Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141\u2013146.", "journal-title": "Diabetes Care"}, {"key": "25_CR9", "doi-asserted-by": "publisher", "first-page": "165", "DOI": "10.1210/jc.84.1.165", "volume": "84", "author": "R.S. Legro", "year": "1999", "unstructured": "Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165\u2013169.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR10", "doi-asserted-by": "publisher", "first-page": "66", "DOI": "10.1210/jc.2004-0229", "volume": "90", "author": "D.A. Ehrmann", "year": "2005", "unstructured": "Ehrmann DA, Kasza K, Azziz R, Legro RS, Ghazzi MN. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:66\u201371.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR11", "doi-asserted-by": "publisher", "first-page": "523", "DOI": "10.2337/diabetes.36.4.523", "volume": "36", "author": "M.I. Harris", "year": "1987", "unstructured": "Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20\u201374 yr. Diabetes 1987;36:523\u2013534.", "journal-title": "Diabetes"}, {"key": "25_CR12", "doi-asserted-by": "publisher", "first-page": "2745", "DOI": "10.1210/jc.2003-032046", "volume": "89", "author": "R. Azziz", "year": "2004", "unstructured": "Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745\u20132749.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR13", "first-page": "1", "volume": "3", "author": "R. Pasquali", "year": "2002", "unstructured": "Pasquali R, Pelusi C, Ragazzini C, Hasanaj R, Gambineri A. Glucose tolerance, insulin secretion and insulin sensitivity in polycystic ovary syndrome. JOP 2002;3:1\u20137.", "journal-title": "JOP"}, {"key": "25_CR14", "doi-asserted-by": "publisher", "first-page": "586", "DOI": "10.2337/diabetes.44.5.586", "volume": "44", "author": "S.L. Kjos", "year": "1995", "unstructured": "Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 1995;44:586\u2013591.", "journal-title": "Diabetes"}, {"key": "25_CR15", "doi-asserted-by": "publisher", "first-page": "1995", "DOI": "10.1093/humrep/16.9.1995", "volume": "16", "author": "R.J. Norman", "year": "2001", "unstructured": "Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 2001;16:1995\u20131998.", "journal-title": "Hum Reprod"}, {"key": "25_CR16", "doi-asserted-by": "publisher", "first-page": "3236", "DOI": "10.1210/jc.2004-1843", "volume": "90", "author": "R.S. Legro", "year": "2005", "unstructured": "Legro RS, Gnatuk CL, Kunselman AR, Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2005;90:3236\u20133242.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR17", "doi-asserted-by": "publisher", "first-page": "302", "DOI": "10.1210/er.2003-0004", "volume": "24", "author": "R.S. Legro", "year": "2003", "unstructured": "Legro RS. Polycystic ovary syndrome and cardioivascular disease: A premature association? Endocr Rev 2003;24:302\u2013312.", "journal-title": "Endocr Rev"}, {"key": "25_CR18", "doi-asserted-by": "publisher", "first-page": "4666", "DOI": "10.1210/jc.86.10.4666", "volume": "86", "author": "E. Diamanti-Kandarakis", "year": "2001", "unstructured": "Diamanti-Kandarakis E, Spina G, Kouli C, Migdalis I. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. J Clin Endocrinol Metab 2001;86:4666\u20134673.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR19", "doi-asserted-by": "publisher", "first-page": "1426", "DOI": "10.1093/humrep/del003", "volume": "21", "author": "E. Diamanti-Kandarakis", "year": "2006", "unstructured": "Diamanti-Kandarakis E, Paterakis T, Alexandraki K, et al. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod 2006;21:1426\u20131431.", "journal-title": "Hum Reprod"}, {"key": "25_CR20", "doi-asserted-by": "publisher", "first-page": "24", "DOI": "10.1093/humrep/15.1.24", "volume": "15", "author": "M.W. Elting", "year": "2000", "unstructured": "Elting MW, Korsen TJ, Rekers-Mombarg LT, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 2000;15:24\u201328.", "journal-title": "Hum Reprod"}, {"key": "25_CR21", "doi-asserted-by": "publisher", "first-page": "724", "DOI": "10.1016/S0015-0282(99)00641-X", "volume": "73", "author": "S.J. Winters", "year": "2000", "unstructured": "Winters SJ, Talbott E, Guzick DS, Zborowski J, McHugh KP. Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril 2000;73:724\u2013729.", "journal-title": "Fertil Steril"}, {"key": "25_CR22", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1161/01.ATV.15.7.821", "volume": "15", "author": "E. Talbott", "year": "1995", "unstructured": "Talbott E, Guzick D, Clerici A, et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 1995;15:821\u2013826.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "25_CR23", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1016/S0889-8545(05)70189-3", "volume": "28", "author": "E.O. Talbott", "year": "2001", "unstructured": "Talbott EO, Zborowski JV, Sutton-Tyrrell K, McHugh-Pemu KP, Guzick DS. Cardiovascular risk in women with polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001;28:111\u2013133.", "journal-title": "Obstet Gynecol Clin North Am"}, {"key": "25_CR24", "doi-asserted-by": "publisher", "first-page": "785", "DOI": "10.1093/humrep/15.4.785", "volume": "15", "author": "D. Cibula", "year": "2000", "unstructured": "Cibula D, Cifkova R, Fanta M, Poledne R, Zivny J, Skibova J. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 2000;15:785\u2013789.", "journal-title": "Hum Reprod"}, {"key": "25_CR25", "doi-asserted-by": "publisher", "first-page": "547", "DOI": "10.1016/S0015-0282(00)00695-6", "volume": "74", "author": "T.L. Loucks", "year": "2000", "unstructured": "Loucks TL, Talbott EO, McHugh KP, Keelan M, Berga SL, Guzick DS. Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome? Fertil Steril 2000;74:547\u2013552.", "journal-title": "Fertil Steril"}, {"key": "25_CR26", "doi-asserted-by": "publisher", "first-page": "2013", "DOI": "10.1210/jc.87.5.2013", "volume": "87", "author": "C.G. Solomon", "year": "2002", "unstructured": "Solomon CG, Hu FB, Dunaif A, et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 2002;87:2013\u20132037.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR27", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1016/S0895-4356(98)00035-3", "volume": "51", "author": "T. Pierpoint", "year": "1998", "unstructured": "Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998;51:581\u2013586.", "journal-title": "J Clin Epidemiol"}, {"key": "25_CR28", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1080/1464727002000198781", "volume": "3", "author": "S. Wild", "year": "2000", "unstructured": "Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 2000;3:101\u2013105.", "journal-title": "Hum Fertil (Camb)"}, {"key": "25_CR29", "doi-asserted-by": "crossref", "first-page": "2414", "DOI": "10.1161/01.ATV.20.11.2414", "volume": "20", "author": "E.O. Talbott", "year": "2000", "unstructured": "Talbott EO, Guzick DS, Sutton-Tyrrell K, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2000;20:2414\u20132421.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "25_CR30", "doi-asserted-by": "publisher", "first-page": "2740", "DOI": "10.1210/jc.2004-2363", "volume": "90", "author": "A. Vryonidou", "year": "2005", "unstructured": "Vryonidou A, Papatheodorou A, Tavridou A, et al. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:2740\u20132746.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR31", "doi-asserted-by": "publisher", "first-page": "2562", "DOI": "10.1210/jc.2003-030334", "volume": "88", "author": "R.C. Christian", "year": "2003", "unstructured": "Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy PF, Fitzpatrick LA. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2562\u20132568.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR32", "doi-asserted-by": "publisher", "first-page": "144", "DOI": "10.1210/jcem-67-1-144", "volume": "67", "author": "M. Nagamani", "year": "1988", "unstructured": "Nagamani M, Hannigan EV, Dinh TV, Stuart CA. Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer. J Clin Endocrinol Metab 1988;67:144\u2013148.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR33", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1002/ijc.2910590303", "volume": "59", "author": "E.M. Rutanen", "year": "1994", "unstructured": "Rutanen EM, Nyman T, Lehtovirta P, Ammala M, Pekonen F. Suppressed expression of insulin-like growth factor binding protein-1 mrna in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors. Int J Cancer 1994;59:307\u2013312.", "journal-title": "Int J Cancer"}, {"key": "25_CR34", "first-page": "123", "volume": "44", "author": "V.B. Gamayunova", "year": "1997", "unstructured": "Gamayunova VB, Bobrov YuF, Tsyrlina EV, Evtushenko TP, Berstein LM. Comparative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma 1997;44:123\u2013126.", "journal-title": "Neoplasma"}, {"key": "25_CR35", "doi-asserted-by": "publisher", "first-page": "356", "DOI": "10.1210/edrv-5-2-356", "volume": "5", "author": "D.S. Straus", "year": "1984", "unstructured": "Straus DS. Growth-stimulatory actions of insulin in vitro and in vivo. Endocr Rev 1984;5:356\u2013369.", "journal-title": "Endocr Rev"}, {"key": "25_CR36", "doi-asserted-by": "publisher", "first-page": "6", "DOI": "10.1016/S0002-9378(98)70244-3", "volume": "179", "author": "M. Nagamani", "year": "1998", "unstructured": "Nagamani M, Stuart CA. Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am J Obstet Gynecol 1998;179:6\u201312.", "journal-title": "Am J Obstet Gynecol"}, {"key": "25_CR37", "first-page": "1531", "volume": "11", "author": "R. Kaaks", "year": "2002", "unstructured": "Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531\u20131543.", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "25_CR38", "doi-asserted-by": "publisher", "first-page": "6", "DOI": "10.3322/canjclin.48.1.6", "volume": "48", "author": "S.H. Landis", "year": "1998", "unstructured": "Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6\u201329.", "journal-title": "CA Cancer J Clin"}, {"key": "25_CR39", "doi-asserted-by": "publisher", "first-page": "1810", "DOI": "10.1016/S0140-6736(03)13409-5", "volume": "361", "author": "P. Hardiman", "year": "2003", "unstructured": "Hardiman P, Pillay OS, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361:1810\u20131812.", "journal-title": "Lancet"}, {"key": "25_CR40", "first-page": "403", "volume": "61", "author": "C.B. Coulam", "year": "1983", "unstructured": "Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403\u2013407.", "journal-title": "Obstet Gynecol"}, {"key": "25_CR41", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/0028-2243(91)90092-Y", "volume": "41", "author": "E. Dahlgren", "year": "1991", "unstructured": "Dahlgren E, Friberg LG, Johansson S, Lindstrom B, Oden A, Samsioe G. Endometrial carcinoma; ovarian dysfunction\u2014a risk factor in young women. Eur J Obstet Gynecol Reprod Biol 1991;41:143\u2013150.", "journal-title": "Eur J Obstet Gynecol Reprod Biol"}, {"key": "25_CR42", "first-page": "11", "volume": "38", "author": "S.P. Ho", "year": "1997", "unstructured": "Ho SP, Tan KT, Pang MW, Ho TH. Endometrial hyperplasia and the risk of endometrial carcinoma. Singapore Med J 1997;38:11\u201315.", "journal-title": "Singapore Med J"}, {"key": "25_CR43", "doi-asserted-by": "publisher", "first-page": "1127", "DOI": "10.1093/jnci/88.16.1127", "volume": "88", "author": "N. Potischman", "year": "1996", "unstructured": "Potischman N, Hoover RN, Brinton LA, et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996;88:1127\u20131135.", "journal-title": "J Natl Cancer Inst"}, {"key": "25_CR44", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1210/jc.85.1.139", "volume": "85", "author": "P. Moghetti", "year": "2000", "unstructured": "Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebocontrolled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000;85:139\u2013146.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR45", "doi-asserted-by": "publisher", "first-page": "1626", "DOI": "10.1210/jc.86.4.1626", "volume": "86", "author": "R. Azziz", "year": "2001", "unstructured": "Azziz R, Ehrmann D, Legro RS, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2001;86:1626\u20131632.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "25_CR46", "first-page": "332", "volume": "88", "author": "H. Speert", "year": "1949", "unstructured": "Speert, H. Carcinoma of the endometrium in young women. Surg Gynecol Obstet 1949;88:332\u2013336.", "journal-title": "Surg Gynecol Obstet"}, {"key": "25_CR47", "doi-asserted-by": "crossref", "first-page": "966", "DOI": "10.1016/0002-9378(51)90298-0", "volume": "61", "author": "M.B. Dockerty", "year": "1951", "unstructured": "Dockerty MB, Lovelady SB, Faust GT. Carcinoma of the corpus uteri in young women. Am J Obstet Gynecol 1951;61:966\u2013981.", "journal-title": "Am J Obstet Gynecol"}, {"key": "25_CR48", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/S0002-9378(16)37277-5", "volume": "73", "author": "R.L. Jackson", "year": "1957", "unstructured": "Jackson RL, Dockerty MB. The Stein Leventhal syndrome. Analysis of 43 cases with special reference to endometrial cancer. Am J Obstet Gynecol 1957;73:161\u2013173.", "journal-title": "Am J Obstet Gynecol"}, {"key": "25_CR49", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1093/ajcp/71.3.253", "volume": "71", "author": "I. Ramzy", "year": "1979", "unstructured": "Ramzy I, Nisker JA. Histologic study of ovaries from young women with endometrial adenocareinoma. Am J Clin Pathol 1979;71:253\u2013256.", "journal-title": "Am J Clin Pathol"}, {"key": "25_CR50", "first-page": "417", "volume": "64", "author": "D.G. Gallup", "year": "1984", "unstructured": "Gallup DG, Stock RJ. Adenocareinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984;64:417\u2013420.", "journal-title": "Obstet Gynecol"}, {"key": "25_CR51", "first-page": "124", "volume": "77", "author": "L.G. Escobedo", "year": "1991", "unstructured": "Escobedo LG, Lee NC, Peterson HB, Wingo PA. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol 1991;77:124\u2013128.", "journal-title": "Obstet Gynecol"}, {"key": "25_CR52", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1016/S0895-4356(98)00035-3", "volume": "51", "author": "T. Pierpoint", "year": "1998", "unstructured": "Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow up. J Clin Epidemiol 1998;51:581\u2013586.", "journal-title": "J Clin Epidemiol"}], "container-title": ["Insulin Resistance and Polycystic Ovarian Syndrome"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-59745-310-3_25", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 11]], "date-time": "2019-03-11T05:52:06Z", "timestamp": 1552283526000}, "score": 42.674896, "issued": {"date-parts": [[2007]]}, "ISBN": ["9781588297631", "9781597453103"], "references-count": 52, "URL": "http://dx.doi.org/10.1007/978-1-59745-310-3_25", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T23:46:55Z", "timestamp": 1575503215267}, "publisher-location": "Cambridge", "reference-count": 0, "publisher": "Cambridge University Press", "isbn-type": [{"value": "9781107478343", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1017/cbo9781107478343.017", "type": "book-chapter", "created": {"date-parts": [[2014, 7, 14]], "date-time": "2014-07-14T10:01:54Z", "timestamp": 1405332114000}, "page": "173-184", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The role of insulin-sensitising drugs in the treatment of polycystic ovary syndrome"], "prefix": "10.1017", "author": [{"given": "Richard S", "family": "Legro", "sequence": "first", "affiliation": []}], "member": "56", "container-title": ["Current Management of Polycystic Ovary Syndrome"], "deposited": {"date-parts": [[2018, 4, 13]], "date-time": "2018-04-13T09:03:54Z", "timestamp": 1523610234000}, "score": 42.522804, "editor": [{"given": "Adam", "family": "Balen", "sequence": "additional", "affiliation": []}, {"given": "Stephen", "family": "Franks", "sequence": "additional", "affiliation": []}, {"given": "Roy", "family": "Homburg", "sequence": "additional", "affiliation": []}, {"given": "Sean", "family": "Kehoe", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[null]]}, "ISBN": ["9781107478343"], "references-count": 0, "URL": "http://dx.doi.org/10.1017/cbo9781107478343.017"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}